Condition
Moderate Hepatic Impairment clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Moderate Hepatic Impairment clinical trials that are recruiting, in United States. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Single-dose capivasertib testing in people with moderate liver impairment
This trial will test how a single oral dose of capivasertib is processed and tolerated in adults with moderate liver impairment compared with people who have normal liver function.
-
Single-dose zanzalintinib testing in people with moderate liver impairment
This will test how one dose of zanzalintinib behaves in the blood of people with moderate liver impairment compared with healthy people.
Related topics
Quick answers
How many Moderate Hepatic Impairment clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.